Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines
- PMID: 8728650
- PMCID: PMC7133382
- DOI: 10.1016/s0959-440x(96)80072-8
Use of macromolecular assemblies as expression systems for peptides and synthetic vaccines
Abstract
The past decade has witnessed the development of numerous systems for the presentation of antigens on the surface of self-assembling macromolecules. Although the sites for insertion were initially chosen empirically, the determination of the three-dimensional structures of a number of carrier macromolecules has enabled structure-based insertional mutagenesis to be used increasingly. Furthermore, it is now feasible to determine the structure of an inserted sequence as presented in a heterologous environment, making it possible to correlate the detailed structure of a peptide with its immunological properties.
Similar articles
-
Synthetic peptide epitope-based polymers: controlling size and determining the efficiency of epitope incorporation.J Pept Res. 2002 Sep;60(3):150-8. doi: 10.1034/j.1399-3011.2002.21009.x. J Pept Res. 2002. PMID: 12213124
-
Viral peptide immunogens: current challenges and opportunities.J Pept Sci. 2007 Dec;13(12):776-86. doi: 10.1002/psc.896. J Pept Sci. 2007. PMID: 17853502 Review.
-
Structure-activity relationships in peptide-antibody complexes: implications for epitope prediction and development of synthetic peptide vaccines.Curr Med Chem. 2009;16(8):953-64. doi: 10.2174/092986709787581914. Curr Med Chem. 2009. PMID: 19275605
-
Engineering and evaluation of amyloid assemblies as a nanovaccine against the Chikungunya virus.Nanoscale. 2018 Nov 7;10(41):19547-19556. doi: 10.1039/c8nr05948a. Epub 2018 Oct 16. Nanoscale. 2018. PMID: 30324958
-
Protein Epitope Mimetics: From New Antibiotics to Supramolecular Synthetic Vaccines.Acc Chem Res. 2017 Jun 20;50(6):1323-1331. doi: 10.1021/acs.accounts.7b00129. Epub 2017 Jun 1. Acc Chem Res. 2017. PMID: 28570824 Review.
Cited by
-
Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult.Vaccines (Basel). 2021 Jul 13;9(7):780. doi: 10.3390/vaccines9070780. Vaccines (Basel). 2021. PMID: 34358196 Free PMC article. Review.
-
Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1.J Virol. 2001 Sep;75(18):8434-9. doi: 10.1128/jvi.75.18.8434-8439.2001. J Virol. 2001. PMID: 11507188 Free PMC article.
-
Norovirus P particle, a novel platform for vaccine development and antibody production.J Virol. 2011 Jan;85(2):753-64. doi: 10.1128/JVI.01835-10. Epub 2010 Nov 10. J Virol. 2011. PMID: 21068235 Free PMC article.
-
Applications of plant viruses in bionanotechnology.Curr Top Microbiol Immunol. 2014;375:61-87. doi: 10.1007/82_2011_184. Curr Top Microbiol Immunol. 2014. PMID: 22038411 Free PMC article. Review.
-
Exploiting plant virus-derived components to achieve in planta expression and for templates for synthetic biology applications.New Phytol. 2013 Oct;200(1):16-26. doi: 10.1111/nph.12204. Epub 2013 Mar 4. New Phytol. 2013. PMID: 23452220 Free PMC article. Review.
References
-
- Francis MJ. Enhanced immunogenicity of recombinant and synthetic peptide vaccines. In: Gregoriadis G, Allison AC, Poste G, editors. Plenum Press; New York: 1991. pp. 13–23. (Vaccines).
-
- Schaaper MM, Lankhof H, Pujik WC, Meloen RH. Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. Mol Immunol. 1989;26:81–85. - PubMed
-
- Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–1317. - PubMed
-
- Scott JK, Craig L. Random peptide libraries. Curr Opin Biotechnol. 1994;5:40–48. - PubMed
-
- O'Neil KT, Hoess RH. Phage display: protein engineering by directed evolution. Curr Opin Struct Biol. 1995;5:443–449. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous